Anthropic is still preparing for a potential initial public offering as soon as November while CEO Dario Amodei warns that AI capabilities could outpace the safeguards designed to control them. The company’s safety debate is now tied to questions about governance, investor influence and the costs of slowing advanced-model development.
Amodei has warned that recursive self-improvement could produce systems that exceed their developers’ ability to understand or control them. He has called for independent reviews and closer cooperation between technology companies and governments. In September, he also said AI development should slow long enough for safety measures to catch up, warning that AI agents could soon coordinate at a scale capable of taking over the internet.
The concerns have already affected Anthropic’s operations. The company paused some high-risk training work involving unreleased models for several weeks in August, then resumed most reinforcement-learning activity after adding monitoring. Anthropic later disclosed misalignment and security incidents involving its models and said it would restrict live internet access during internal evaluations until its systems can reliably detect similar problems.
Anthropic is expanding outside scrutiny, giving six researchers from the nonprofit METR access comparable to that of internal safety teams. METR can publish its findings without company approval, but it cannot decide whether a model is released. New York City Comptroller Mark Levine urged Anthropic on Oct. 14 to delay its IPO until safety and governance issues are addressed; Anthropic subsequently contacted him, with no reported change to the proposed timetable.
A draft prospectus warned that the arrangement could produce decisions that do not prioritize financial performance or shareholder value, leaving public investors with limited influence over major corporate choices.
Anthropic is also seeking a larger government role in deciding when dangerous AI systems can be commercialized. Draft legislation the company has presented to Congress would allow the Commerce Department and federal courts to block certain models judged dangerous, a framework that could delay product launches if enacted.
The IPO’s financial case is facing pressure independent of the safety restrictions. No established evidence links that reassessment to the safety measures.
Analysis: Anthropic is approaching a public-market test in which its safety commitments, concentrated founder control and aggressive growth plans will be evaluated at the same time. The company has not abandoned the November timetable, but its disclosures make clear that safety decisions can affect training, evaluation and commercialization even as it seeks a valuation measured in trillions of dollars.